Enzyme Immunoassay (EIA) Reagents and Kits Market Size, Share & Trends Analysis Report By Product Type (reagents and kits), Technology (competitive ELISA, indirect ELISA, sandwich ELISA, and multiple/portable ELISA), Applications, Region And Segment Forecasts, 2023-2031.

Report Id: 1059 Pages: 170 Last Updated: 08 November 2024 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

The Enzyme Immunoassay (EIA) Reagents and Kits Market Size is valued at 19.80 Billion in 2022 and is predicted to reach 31.60 Billion by the year 2031 at an 5.5 % CAGR during the forecast period for 2023-2031.

Enzyme Immunoassay (EIA) Reagents and Kits Market

Enzyme Immunoassay (EIA) test is one of laboratory technology that is used for measuring the concentration of analytes such as antigen and antibodies in solution. Enzyme Immunoassay (EIA) test includes various types of enzymes such as alkaline phosphatases, glucose oxidase, and carbonic anhydrase the result can be detected by fluorometry or photometry. Enzyme Immunoassay (EIA) is used as a screening test in the treatment of various infectious diseases such as otavirus, syphilis, Rocky Mountain spotted fever, pernicious anemia, and HIV AIDS. Enzyme Immunoassay (EIA) finds application in different healthcare facilities that includes diagnostic laboratories, hospital, and research laboratories. In addition, Enzyme Immunoassay (EIA) is used in academics, and food industry for different applications.

Increasing incidence of diseases such as infectious diseases and cancer is one of the primary driver associated with the growth of global Enzyme Immunoassay (EIA) Reagents and Kits market.  Also, continuous development in biomarkers, cost benefit as compared to other diagnostic tests, and increasing adoption of automated platforms for Enzyme Immunoassay (EIA) has led to increasing demand for Enzyme Immunoassay (EIA) test on the market.Based on the product type, market has been segmented into reagents and kits. In terms of technology, enzyme Immunoassays are further classified into competitive ELISA, indirect ELISA, sandwich ELISA, and multiple/portable ELISA. Based on application, Enzyme Immunoassay (EIA) Reagents and Kits market categorised into Infectious diseases, Cardiology, Oncology, Bone and Mineral, Autoimmunity, Endocrinology, Toxicology, Neonatal screening, Hematology, and Others. In term of end-user, the market has been segmented into hospital laboratories, clinical laboratories, pharmaceutical & biotechnology companies, reference laboratories, academics and others.

Market Segmentation

At regional level, global Enzyme Immunoassay (EIA) Reagents and Kits market has been segmented into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. In terms of revenue, North America is major contributor for Enzyme Immunoassay (EIA) test products. Higher adoption of new technologically advanced products and rising awareness for early disease diagnosis propels market growth in the region. Increasing awareness of diseases among peoples that leads to regular check-ups for disease management drives the Enzyme Immunoassay (EIA) test market in North America. The market in North Americas is expected to sustain its growth in the forecast period. North America is followed by Europe which is second largest revenue contributor for global Enzyme Immunoassay (EIA) Reagents and Kits market. The market in Europe is growing steadily because of high prevalence and incidence of disease in the region.  Also, the presence of well-established diagnostic laboratories that offers fully automated Enzyme Immunoassay (EIA) test systems with increased efficiency of tests. Asia Pacific is third promising revenue contributor which is expected to grow at rapid pace in upcoming year. Countries such as Japan, India and China are major contributors for this market. Emerging and huge population base countries such as China and India offers tremendous market opportunities. Many global manufacturers are trying to capture this market.

Competitive Landscape

Some of The Key Players in The Enzyme Immunoassay (EIA) Reagents and Kits Market:

  • American Laboratory Products Company, Ltd.
  • Affymetrix, Inc.
  • Thermo Fisher Scientific. Inc.
  • BD Biosciences
  • bioMérieux SA
  • Beckman Coulter Inc.
  • Ortho-Clinical Diagnostics, Inc.
  • R&D Systems Inc.
  • QIAGEN
  • Quidel
  • Life Technologies Corporation
  • ZEUS Scientific, Inc
  • Other Prominent Players

The Enzyme Immunoassay (EIA) Reagents and Kits Market Report Scope

Report Attribute Specifications
Market Size Value In 2022 USD 19.80 Billion
Revenue Forecast In 2031 USD 31.60 Billion
Growth Rate CAGR CAGR of 5.5 % from 2023 to 2031
Quantitative Units Representation of revenue in US$ Billion and CAGR from 2023 to 2031
Historic Year 2019 to 2022
Forecast Year 2023-2031
Report Coverage The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered By Product Type, By Technology, By Applications
Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia
Competitive Landscape American Laboratory Products Company, Ltd., Affymetrix, Inc., Thermo Fisher Scientific. Inc., BD Biosciences, bioMérieux SA, Beckman Coulter Inc., Ortho-Clinical Diagnostics, Inc., R&D Systems Inc., QIAGEN, Quidel, Life Technologies Corporation, ZEUS Scientific, Inc, and Others
Customization Scope Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing and Available Payment Methods Explore pricing alternatives that are customized to your particular study requirements.

Global Enzyme Immunoassay (EIA) Reagents and Kits Market Segmentation

Global Enzyme Immunoassay (EIA) Reagents and Kits Market Outlook (Revenue, US$ Mn, 2019 – 2030) By Technology

  • Competitive ELISA
  • Indirect ELISA
  • Sandwich ELISA
  • Multiple/portable ELISA

Enzyme Immunoassay (EIA) Reagents and Kits Market

Global Enzyme Immunoassay (EIA) Reagents and Kits Market Outlook (Revenue, US$ Mn, 2019 – 2030) By Product Type

  • Reagents
  • Kits

Global Enzyme Immunoassay (EIA) Reagents and Kits Market Outlook (Revenue, US$ Mn, 2019 – 2030) By Application

  • Infectious Diseases
  • Cardiology
  • Oncology
  • Bone and Mineral
  • Autoimmunity
  • Endocrinology
  • Toxicology
  • Neonatal screening
  • Hematology
  • Others

Global Enzyme Immunoassay (EIA) Reagents and Kits Market Outlook (Revenue, US$ Mn, 2019 – 2030) By Region

  • Asia Pacific
    • India
    • China
    • Japan
    • South Korea
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Europe
    • K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa
  • North America
    • U.S.
    • Canada

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
6125
Security Code field cannot be blank!

Frequently Asked Questions

The Enzyme Immunoassay (EIA) Reagents and Kits Market Size is valued at 19.80 Billion in 2022 and is predicted to reach 31.60 Billion by the year 2031

The Enzyme Immunoassay (EIA) Reagents and Kits Market is expected to grow at a 5.5 % CAGR during the forecast period for 2023-2031.

American Laboratory Products Company, Ltd., Affymetrix, Inc., Thermo Fisher Scientific. Inc., BD Biosciences, bioMérieux SA, Beckman Coulter Inc., Ort

Product Type, Technology, and Applications are the key segments of the Enzyme Immunoassay (EIA) Reagents and Kits Market.

North American region is leading the Enzyme Immunoassay (EIA) Reagents and Kits Market.
Send Me the Sample Report Enquiry Before Buying